Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| SABS | SAB BIOTHERAPEUTICS INC | $193.61M | 50,951,037 | 41.21% | 58.79% | Net Buying | |||
| SEPN | SEPTERNA INC | $1.11B | 44,906,374 | 66.75% | 33.25% | Net Buying | Net Buying | ||
| PAR | PAR TECHNOLOGY CORP | $569.96M | 41,152,632 | 76.96% | 23.04% | Net Buying | Net Selling | ||
| ORIC | ORIC PHARMACEUTICALS INC | $962.71M | 103,517,562 | 84.83% | 15.17% | Net Selling | Net Buying | ||
| SSYS | STRATASYS LTD | $796.52M | 86,109,936 | 45.67% | 15.50% | ||||
| SGP | SPYGLASS PHARMA INC | $837.50M | 33,426,557 | 0.00% | 100.00% | Net Buying | Net Buying | ||
| BIOA | BIOAGE LABS INC | $819.25M | 44,379,753 | 53.01% | 22.30% | Net Selling | Net Buying | ||
| IAC | IAC INC | $3.14B | 74,380,054 | 95.50% | 4.26% | Net Selling | Net Selling | ||
| PTCT | PTC THERAPEUTICS INC | $5.51B | 82,774,730 | 86.56% | 13.44% | Net Selling | Net Selling | ||
| EVER | EVERQUOTE INC | $727.63M | 35,373,278 | 59.48% | 40.52% | Net Selling | Net Selling | ||
| CLSK | CLEANSPARK INC | $3.71B | 255,752,913 | 74.93% | 25.07% | Net Selling | Net Selling | ||
| STOK | STOKE THERAPEUTICS INC | $1.97B | 59,150,790 | 52.83% | 47.17% | Net Selling | Net Selling | ||
| IDYA | IDEAYA BIOSCIENCES INC | $2.53B | 87,860,920 | 92.66% | 7.34% | Net Buying | Net Buying | ||
| PYXS | PYXIS ONCOLOGY INC | $144.51M | 62,831,246 | 48.06% | 37.32% | ||||
| VIST | VISTA ENERGY SAB DE CV | $7.21B | 105,186,958 | 43.84% | 10.80% | Net Selling | Net Selling | ||
| AHCO | ADAPTHEALTH CORP | $1.55B | 136,054,152 | 45.11% | 54.89% | Net Buying | Net Buying | ||
| AMBA | AMBARELLA INC | $3.31B | 43,788,879 | 71.66% | 28.34% | Net Selling | Net Selling | ||
| AVTX | AVALO THERAPEUTICS INC | $497.02M | 22,788,452 | 19.65% | 80.35% | Net Selling | Net Selling | ||
| KGC | KINROSS GOLD CORP | $36.75B | 1,194,109,463 | 58.97% | 0.00% | ||||
| ZLAB | ZAI LAB LTD | $2.32B | 1,106,407,390 | 2.62% | 1.78% | Net Buying | Net Buying | ||
| HTHT | H WORLD GROUP LTD | $14.99B | 3,071,525,690 | 4.53% | 0.54% | Net Selling | Net Selling | ||
| ONC | BEONE MEDICINES LTD | $34.87B | 1,445,262,342 | 2.34% | 31.96% | Net Buying | Net Buying | ||
| PPTA | PERPETUA RESOURCES CORP | $3.74B | 124,949,691 | 58.90% | 41.10% | Net Buying | Net Selling | ||
| TRAX | FIRST TRACKS BIOTHERAPEUTICS INC | N/A | 34,748,841 | 0.00% | 24.51% | Net Selling | Net Selling | ||
| XNCR | XENCOR INC | $954.14M | 73,338,642 | 71.97% | 28.03% | Net Selling | Net Selling | ||
| GTN | GRAY MEDIA INC | $573.88M | 103,776,139 | 69.85% | 30.15% | Net Buying | Net Buying | ||
| DBVT | DBV TECHNOLOGIES SA | $1.19B | 296,042,447 | 5.46% | 11.37% | Net Selling | |||
| ANRO | ALTO NEUROSCIENCE INC | $782.35M | 31,945,516 | 76.65% | 21.03% | Net Selling | Net Selling | ||
| PEPG | PEPGEN INC | $127.52M | 69,115,292 | 83.00% | 9.75% | Net Buying | Net Selling | ||
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUTICS INC | $666.67M | 80,032,823 | 63.09% | 36.91% | Net Buying | Net Selling | ||
| ONT | ONTERRIS INC | $791.57M | 35,980,650 | 90.50% | 9.50% | Net Selling | Net Buying | ||
| CTMX | CYTOMX THERAPEUTICS INC | $702.87M | 170,186,742 | 84.65% | 12.87% | Net Selling | Net Selling | ||
| MGTX | MEIRAGTX HOLDINGS PLC | $806.32M | 81,446,126 | 57.44% | 42.56% | Net Selling | Net Buying | ||
| MGPI | MGP INGREDIENTS INC | $412.89M | 21,371,237 | 25.36% | 74.64% | Net Selling | Net Selling | ||
| CPS | COOPER-STANDARD HOLDINGS INC | $541.28M | 17,637,009 | 66.18% | 20.02% | Net Selling | Net Selling | ||
| CSTL | CASTLE BIOSCIENCES INC | $735.85M | 29,731,198 | 86.04% | 13.96% | Net Selling | Net Selling | ||
| DNLI | DENALI THERAPEUTICS INC | $3.24B | 158,591,491 | 62.97% | 37.03% | Net Selling | |||
| NYXH | NYXOAH SA | $138.55M | 43,026,460 | 8.61% | 0.00% | ||||
| TYRA | TYRA BIOSCIENCES INC | $1.82B | 53,867,115 | 62.54% | 37.46% | Net Buying | Net Selling | ||
| SYRE | SPYRE THERAPEUTICS INC | $6.34B | 86,841,253 | 75.87% | 24.13% | Net Selling | Net Selling | ||
| GLUE | MONTE ROSA THERAPEUTICS INC | $1.63B | 80,015,667 | 34.80% | 65.20% | Net Selling | Net Selling | ||
| CLYM | CLIMB BIO INC | $583.72M | 47,767,980 | 65.37% | 13.15% | Net Buying | Net Selling | ||
| CLFD | CLEARFIELD INC | $414.39M | 13,685,411 | 60.37% | 39.63% | Net Buying | Net Selling | ||
| NEXN | NEXXEN INTERNATIONAL LTD | $214.72M | 56,284,083 | 65.34% | 2.70% | ||||
| ALLO | ALLOGENE THERAPEUTICS INC | $563.13M | 243,777,920 | 66.72% | 31.96% | Net Selling | Net Selling | ||
| SLDB | SOLID BIOSCIENCES INC | $708.42M | 98,391,314 | 55.24% | 44.76% | Net Selling | Net Selling | ||
| PCVX | VAXCYTE INC | $8.25B | 144,397,682 | 88.01% | 11.99% | Net Selling | Net Selling | ||
| CGEM | CULLINAN THERAPEUTICS INC | $907.29M | 60,526,128 | 56.33% | 43.67% | Net Buying | Net Selling | ||
| MAZE | MAZE THERAPEUTICS INC | $1.32B | 49,708,658 | 88.40% | 11.60% | Net Selling | Net Buying | ||
| CATX | PERSPECTIVE THERAPEUTICS INC | $435.23M | 113,933,436 | 23.17% | 76.83% | Net Buying | |||
| TTAN | SERVICETITAN INC | $5.99B | 95,261,223 | 46.55% | 53.45% | Net Selling | Net Selling | ||
| NG | NOVAGOLD RESOURCES INC | $3.96B | 438,780,614 | 61.10% | 38.90% | Net Buying | Net Buying | ||
| EVEX | EVE HOLDING INC | $1.13B | 348,304,584 | 5.18% | 94.82% | Net Buying | |||
| OLMA | OLEMA PHARMACEUTICALS INC | $1.32B | 87,156,961 | 78.20% | 21.80% | Net Selling | Net Buying | ||
| CADL | CANDEL THERAPEUTICS INC | $558.87M | 73,246,927 | 32.27% | 24.06% | Net Buying | Net Buying | ||
| PUBM | PUBMATIC INC | $480.69M | 47,405,424 | 58.32% | 4.18% | Net Selling | Net Selling | ||
| B | BARRICK MINING CORP | $69.66B | 1,675,360,395 | 61.53% | 0.00% | ||||
| EVTL | VERTICAL AEROSPACE LTD | $346.33M | 127,328,004 | 59.23% | 12.19% | Net Selling | Net Selling | ||
| EXE | EXPAND ENERGY CORP | $23.19B | 239,228,849 | 90.40% | 9.60% | Net Buying | Net Selling | ||
| OKLO | OKLO INC | $13.82B | 173,568,788 | 43.11% | 34.66% | Net Selling | Net Selling | ||
| KPTI | KARYOPHARM THERAPEUTICS INC | $165.46M | 18,343,968 | 20.88% | 79.12% | Net Selling | Net Selling | ||
| TDUP | THREDUP INC | $650.37M | 129,040,846 | 73.39% | 8.81% | Net Selling | Net Selling | ||
| ABCL | ABCELLERA BIOLOGICS INC | $1.53B | 303,160,487 | 35.76% | 44.36% | Net Buying | Net Buying | ||
| OFIX | ORTHOFIX MEDICAL INC | $492.74M | 40,421,652 | 77.04% | 22.96% | Net Buying | Net Buying | ||
| KYTX | KYVERNA THERAPEUTICS INC | $572.37M | 60,439,893 | 53.71% | 46.29% | Net Buying | |||
| OBIO | ORCHESTRA BIOMED HOLDINGS INC | $240.52M | 58,520,901 | 35.29% | 64.71% | Net Buying | Net Selling | ||
| TRVI | TREVI THERAPEUTICS INC | $2.02B | 141,979,708 | 43.05% | 56.95% | Net Buying | |||
| BEAT | HEARTBEAM INC | $35.17M | 41,087,871 | 11.11% | 17.25% | Net Buying | Net Buying | ||
| IVA | INVENTIVA SA | $1.04B | 193,236,978 | 24.17% | 0.00% | ||||
| SAIL | SAILPOINT INC | $6.55B | 563,803,428 | 53.31% | 46.69% | Net Selling | Net Selling | ||
| GLXY | GALAXY DIGITAL INC | $12.11B | 389,096,394 | 33.07% | 1.51% | Net Selling | Net Selling | ||
| MBOT | MICROBOT MEDICAL INC | $147.08M | 67,158,044 | 16.96% | 47.40% | ||||
| MNPR | MONOPAR THERAPEUTICS | $427.36M | 6,692,140 | 22.50% | 77.50% | Net Selling | Net Selling | ||
| FHTX | FOGHORN THERAPEUTICS INC | $264.66M | 56,551,289 | 74.05% | 15.02% | ||||
| NKLR | TERRA INNOVATUM GLOBAL NV | $466.80M | 70,300,948 | 26.88% | 0.00% | ||||
| ZURA | ZURA BIO LTD | $463.97M | 94,880,710 | 44.38% | 55.62% | Net Buying | Net Buying | ||
| CAN | CANAAN INC | $387.20M | 10,431,482,973 | 1.54% | 3.56% | ||||
| ADPT | ADAPTIVE BIOTECHNOLOGIES CORP | $2.31B | 160,044,392 | 63.04% | 36.96% | Net Selling | Net Selling | ||
| RAPP | RAPPORT THERAPEUTICS INC | $1.77B | 47,792,943 | 76.59% | 23.41% | Net Selling | Net Selling | ||
| PALI | PALISADE BIO INC | $331.77M | 165,884,817 | 81.91% | 5.00% | Net Buying | Net Selling | ||
| NWSA | NEWS CORP | $14.55B | 555,378,060 | 85.11% | 14.89% | Net Selling | Net Selling | ||
| TBN | TAMBORAN RESOURCES CORP | $798.04M | 22,639,513 | 35.96% | 30.29% | Net Buying | Net Buying | ||
| SSTI | SOUNDTHINKING INC | $87.05M | 12,953,937 | 54.60% | 45.40% | Net Buying | Net Buying | ||
| SHEL | SHELL PLC | $248.08B | 5,689,891,670 | 6.36% | 0.00% | ||||
| VLRS | CONTROLADORA VUELA COMPANIA DE AVIACION SAB DE CV | $915.29M | 1,165,976,677 | 3.82% | 4.62% | ||||
| ALXO | ALX ONCOLOGY HOLDINGS INC | $275.06M | 131,608,278 | 22.19% | 11.13% | Net Buying | Net Selling | ||
| GIL | GILDAN ACTIVEWEAR INC | $11.35B | 185,173,000 | 78.56% | 0.00% | ||||
| LXEO | LEXEO THERAPEUTICS INC | $461.56M | 74,087,063 | 91.10% | 8.90% | Net Selling | Net Selling | ||
| DEFT | DEFI TECHNOLOGIES INC | $302.49M | 385,827,975 | 11.74% | 0.00% | ||||
| WCN | WASTE CONNECTIONS INC | $39.00B | 254,080,912 | 85.73% | 0.58% | Net Selling | Net Selling | ||
| JD | JDCOM INC | $42.17B | 2,748,133,731 | 6.54% | 0.44% | Net Selling | Net Selling | ||
| JBIO | JADE BIOSCIENCES INC | $1.24B | 49,316,287 | 71.10% | 28.90% | Net Buying | |||
| VTVT | VTV THERAPEUTICS INC | $124.78M | 3,938,654 | 2.07% | 97.93% | Net Buying | |||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $11.27M | 12,810,377 | 51.46% | 48.54% | ||||
| EVMN | EVOMMUNE INC | $858.32M | 36,018,372 | 56.26% | 43.74% | Net Buying | Net Buying | ||
| IKT | INHIBIKASE THERAPEUTICS INC | $265.39M | 132,032,636 | 80.60% | 16.42% | Net Buying | |||
| GPCR | STRUCTURE THERAPEUTICS INC | $2.89B | 212,525,437 | 31.36% | 10.38% | Net Selling | Net Selling | ||
| RLMD | RELMADA THERAPEUTICS INC | $824.44M | 104,890,223 | 49.23% | 3.37% | Net Buying | |||
| ATAI | ATAIBECKLEY INC | $1.52B | 364,745,985 | 15.24% | 32.96% | Net Buying | Net Buying | ||
| OVID | OVID THERAPEUTICS INC | $366.61M | 131,874,634 | 46.85% | 14.10% | Net Buying | Net Buying |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.